Almac meets evolving trial design with ‘on demand’ supply solution

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Yozayo)
(Image: Getty/Yozayo)

Related tags: Almac, Almac clinical services, Almac group, Trial supply management, Clinical supply, Clinical trial, Supply chain

In an aim to optimize the performance of changing clinical trials, Almac Clinical Services launched a supply chain solution – Almac Adapt – to provide sponsors with an adaptive supply strategy.

Almac Clinical Services, part of the Almac Group, said with the growth of biopharmaceutical development and clinical trials there has been an evolution in trial designs to match these targeted therapies that pose additional challenges.

 “The clinical trial landscape is experiencing rapid growth in biologics and personalized medicine. Our clients are faced with increasing challenges to overcome, which have resulted in aggressive study timelines, rising costs, the need for supply chain flexibility and the necessity to supply smaller, yet more global, clinical studies for specifically targeted populations,”​ an Almac spokesperson told us.

The new solution is a secondary packaging and labeling approach in which an operation is triggered by a distribution order and is sent directly to the patient or trial site.

The Almac spokesperson said the solution can reduce the supply cycle time to provide a ‘tighter control’ of supply including full late-stage customization of clinical supply kits to increase efficiency across the entire clinical supply chain.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more